argenx announces initial results from a Phase 1 single ascending dose study of ARGX-113 in healthy volunteers

Monday, January 4, 2016 1 min read

Key Takeaway: argenx announces initial results from a Phase 1 single ascending dose study of ARGX-113 in healthy volunteers

Full Press Release Details

argenx announces initial results from a Phase 1 single ascending dose study of ARGX-113 in healthy volunteers.